Overview

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

Status:
Completed
Trial end date:
2014-05-30
Target enrollment:
Participant gender:
Summary
This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.
Phase:
Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals